Open AccessCFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma
Author(s) -
Cerise YuenKi Chan,
Dah Ming Chiu,
Vincent WaiHin Yuen,
CheukTing Law,
Bowie PoYee Wong,
Kelsie Thu,
David W. Cescon,
Isabel SoriaBretones,
Jacinth WingSum Cheu,
Derek Lee,
Aki PuiWah Tse,
Misty Shuo Zhang,
Kel Vin Tan,
Irene OiLin Ng,
PekLan Khong,
Thomas Yau,
Mark R. Bray,
Tak W. Mak,
Carmen ChakLui Wong
Publication year - 2022
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2119514119
Subject(s) - cancer research , immune checkpoint , immune system , biology , hepatocellular carcinoma , cancer cell , dna damage , cd8 , foxp3 , cancer , cytotoxic t cell , immunology , immunotherapy , dna , biochemistry , in vitro , genetics